Advancing vaccinology capacity: education and efforts in vaccine development and manufacturing across Africa
JP Sinumvayo, PC Munezero, AT Tope… - Vaccines, 2024 - pmc.ncbi.nlm.nih.gov
Africa, home to the world's second-largest population of approximately 1.3 billion, grapples
with significant challenges in meeting its medical needs, particularly in accessing quality …
with significant challenges in meeting its medical needs, particularly in accessing quality …
Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management
PS Nyasulu, CO Doumbia, V Ngah… - Current Opinion in …, 2024 - journals.lww.com
To effectively manage MDR-TB and its co-morbidity with HIV/AIDS, proactive screening
programs are imperative. The review highlights the necessity of active follow-up strategies to …
programs are imperative. The review highlights the necessity of active follow-up strategies to …
Recent Advancements in Benzothiazinones (BTZ) Analogs as DprE1 Inhibitor for Potent Antitubercular Therapeutics
Benzothiazinone analogs have emerged as a promising class of compounds having potent
antimycobacterial activity, particularly against Mycobacterium tuberculosis, the pathogen …
antimycobacterial activity, particularly against Mycobacterium tuberculosis, the pathogen …
[HTML][HTML] Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine …
Drug-resistant tuberculosis (DR-TB) and HIV coinfection present a conundrum to public
health globally and the achievement of the global END TB strategy in 2035. A descriptive …
health globally and the achievement of the global END TB strategy in 2035. A descriptive …
[HTML][HTML] Clinical epidemiology, genetic diversity, and drug susceptibility patterns by whole genome sequencing of Mycobacterium tuberculosis complex isolates in …
BR Adegbite, V Dreyer, JB Agbo, RC Mevyann… - IJID Regions, 2025 - Elsevier
Objectives This study aimed to investigate genotypic characteristics and drug resistance
profiles of Mycobacterium tuberculosis complex (Mtbc) strains isolated from patients with …
profiles of Mycobacterium tuberculosis complex (Mtbc) strains isolated from patients with …
[PDF][PDF] Predicting Treatment Outcomes in Patients with Drug-resistant Tuberculosis and HIV Co-infection Using a Supervised Machine Learning Algorithm
Drug-resistant tuberculosis (DR-TB) and HIV-coinfection present a conundrum to public
health globally and the achievement of the global END TB strategy in 2035. A descriptive …
health globally and the achievement of the global END TB strategy in 2035. A descriptive …
Tuberculose pré-et ultrarésistante à Libreville, Gabon
UD Kombila, CM Boulingui, F N'Gomanda… - Revue des Maladies …, 2024 - Elsevier
Résumé Introduction Très peu de travaux abordent la tuberculose (TB) pré-et ultrarésistante.
Objectif Présenter l'épidémiologie de la tuberculose pré-et ultrarésistante et le devenir des …
Objectif Présenter l'épidémiologie de la tuberculose pré-et ultrarésistante et le devenir des …
APPORT DU GENEXPERT MTB/RIF DANS LA DETECTION DE L'INFECTION A MYCOBACTERIUM TUBERCULOSIS ET LA RESISTANCE A LA RIFAMPICINE A L' …
M MUNKOMBWE, K BUKASA… - Tanganyika …, 2023 - tanganyikajournalofscience.org
Résumé Introduction: La tuberculose pharmaco-résistante est une menace réelle sur notre
capacité d'élimination de la tuberculose comme problème de santé publique. La prévention …
capacité d'élimination de la tuberculose comme problème de santé publique. La prévention …
[引用][C] Epidemiological profile and outpatient follow-up for pre-and extensively drug-resistant tuberculosis in Libreville, Gabon
UD KOMBILA, CM BOULINGUI, F N'GOMANDA… - 2024
[引用][C] JOURNAL OF FUNCTIONAL VENTILATION AND PULMONOLOGY [Journal de la Fonction Ventilatoire et de Pneumologie]
UD KOMBILA, CM BOULINGUI, F N'GOMANDA…